{"id":"https://openalex.org/W1998657382","doi":"https://doi.org/10.1254/jjp.90.218","title":"Development of the Chymase Inhibitor as an Anti-Tissue-Remodeling Drug: Myocardial Infarction and Some Other Possibilities","display_name":"Development of the Chymase Inhibitor as an Anti-Tissue-Remodeling Drug: Myocardial Infarction and Some Other Possibilities","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W1998657382","doi":"https://doi.org/10.1254/jjp.90.218","mag":"1998657382","pmid":"https://pubmed.ncbi.nlm.nih.gov/12499575"},"language":"en","primary_location":{"id":"doi:10.1254/jjp.90.218","doi":"https://doi.org/10.1254/jjp.90.218","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.90.218","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0021519819300253/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S0021519819300253/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090460998","display_name":"Yoshikazu Sukenaga","orcid":"https://orcid.org/0000-0001-8479-3842","observed_orcids":["https://orcid.org/0000-0001-8479-3842"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshikazu Sukenaga","raw_affiliation_strings":["Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan. yoshikazu.sukenaga@nipponkayaku.co.jp","Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan. yoshikazu.sukenaga@nipponkayaku.co.jp","institution_ids":["https://openalex.org/I4210150228"]},{"raw_affiliation_string":"Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066064150","display_name":"Keiichi Kamoshita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiichi Kamoshita","raw_affiliation_strings":["Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo 115-8588, Japan","Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo 115-8588, Japan","institution_ids":["https://openalex.org/I4210150228"]},{"raw_affiliation_string":"Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038223019","display_name":"Shinji Takai","orcid":"https://orcid.org/0000-0003-3963-3983","observed_orcids":["https://orcid.org/0000-0003-3963-3983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shinji Takai","raw_affiliation_strings":["Department of Pharmacology, Osaka Medical College, Osaka 569-8686, Japan","Department of Pharmacology, Osaka Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka Medical College, Osaka 569-8686, Japan","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Osaka Medical College","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113772330","display_name":"Mizuo Miyazaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mizuo Miyazaki","raw_affiliation_strings":["Department of Pharmacology, Osaka Medical College, Osaka 569-8686, Japan","Department of Pharmacology, Osaka Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka Medical College, Osaka 569-8686, Japan","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Osaka Medical College","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090460998"],"corresponding_institution_ids":["https://openalex.org/I4210150228"],"apc_list":null,"apc_paid":null,"fwci":2.1142,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.88146546,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"90","issue":"3","first_page":"218","last_page":"222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.08389999717473984,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.04729999974370003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chymase","display_name":"chymase","score":0.8109999895095825},{"id":"https://openalex.org/keywords/chymase-inhibitors","display_name":"chymase inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tissue-remodeling","display_name":"tissue remodeling","score":0.9890000224113464},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9300000071525574},{"id":"https://openalex.org/keywords/neointimal-hyperplasia","display_name":"intimal hyperplasia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8889999985694885},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/bladder-fibrosis","display_name":"bladder fibrosis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/interstitial-cystitis","display_name":"interstitial cystitis","score":1.0},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6430000066757202},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.6259999871253967},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6370000243186951},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.5619999766349792},{"id":"https://openalex.org/keywords/passive-cutaneous-anaphylaxis","display_name":"passive cutaneous anaphylaxis","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C2780614898","wikidata":"https://www.wikidata.org/wiki/Q5118578","display_name":"Chymase","level":3,"score":0.9779959917068481},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6144558787345886},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6126541495323181},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5511413216590881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5381408929824829},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.4327641725540161},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.4197232127189636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33255064487457275},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20781725645065308},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18211138248443604},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11951395869255066},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10263380408287048},{"id":"https://openalex.org/C2779726688","wikidata":"https://www.wikidata.org/wiki/Q191989","display_name":"Mast cell","level":2,"score":0.08557528257369995},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020257","descriptor_name":"Ventricular Remodeling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D053818","descriptor_name":"Chymases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1254/jjp.90.218","doi":"https://doi.org/10.1254/jjp.90.218","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.90.218","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0021519819300253/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:12499575","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12499575","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1254/jjp.90.218","doi":"https://doi.org/10.1254/jjp.90.218","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.90.218","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0021519819300253/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998657382.pdf","grobid_xml":"https://content.openalex.org/works/W1998657382.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1521804991","https://openalex.org/W1577884079","https://openalex.org/W1777015161","https://openalex.org/W1933108396","https://openalex.org/W1973135001","https://openalex.org/W1995941626","https://openalex.org/W1996690543","https://openalex.org/W2015719530","https://openalex.org/W2023531166","https://openalex.org/W2051784480","https://openalex.org/W2054037372","https://openalex.org/W2071660979","https://openalex.org/W2128819566","https://openalex.org/W2138013258","https://openalex.org/W2143658570","https://openalex.org/W2155326631","https://openalex.org/W2164967423","https://openalex.org/W2413838572","https://openalex.org/W2415550289"],"related_works":["https://openalex.org/W2165254129","https://openalex.org/W2014205789","https://openalex.org/W7098735801","https://openalex.org/W2060383269","https://openalex.org/W2035777338","https://openalex.org/W2028032945","https://openalex.org/W2064572992","https://openalex.org/W2038678182","https://openalex.org/W1973135001","https://openalex.org/W1990315339"],"abstract_inverted_index":{"Chymase":[0],"leading":[1],"to":[2,7,37,123],"tissue":[3,116,125,153,170,178,182,208],"remodeling":[4,171,209],"is":[5,84],"expected":[6],"be":[8],"a":[9,166],"potent":[10,91,148],"pharmaceutical":[11],"target.":[12],"Its":[13],"functions":[14,72],"in":[15,44,67,73,111,169,190,210],"vivo":[16,74],"are":[17,75],"still":[18],"unclear,":[19],"because":[20],"of":[21,23,65,80,105,150,174],"lack":[22],"orally":[24,144,198],"available":[25],"inhibitors.":[26],"Recently,":[27],"however,":[28],"the":[29,63,78,118,175,197],"chymase":[30,71,82,92,126,164,188,200],"inhibitor":[31,83,201],"NK3201":[32,66,89,106,146,202],"(2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidin-1-yl)-N-[[3,4-dioxo-1-phenyl-7-(2-pyridyloxy)]-2-heptyl]":[33],"acetamide)":[34],"was":[35,127],"demonstrated":[36],"have":[38,204],"oral":[39],"activity":[40,122],"against":[41],"neointimal":[42],"hyperplasia":[43],"dog":[45],"models":[46],"(Takai":[47],"S.":[48],"et":[49],"al.,":[50],"Life":[51],"Sci":[52],"69,":[53],"1725":[54],"-":[55],"1732":[56],"(2001)).":[57],"In":[58,86,133],"this":[59,81],"review,":[60],"by":[61],"showing":[62],"efficacy":[64],"some":[68],"hamster":[69],"models,":[70,143],"summarized,":[76],"and":[77,96,120,139,157,181],"potency":[79],"introduced.":[85],"vitro":[87],"study,":[88],"showed":[90,147],"specific":[93],"inhibitory":[94],"activity,":[95],"Dixon":[97],"plot":[98],"analysis":[99],"indicated":[100,187],"competitive":[101],"inhibition.":[102],"Oral":[103],"administration":[104],"into":[107],"normal":[108],"rats":[109],"resulted":[110],"rapid":[112],"spread":[113],"over":[114],"every":[115],"except":[117],"brain,":[119],"sufficient":[121],"inhibit":[124],"detected":[128],"even":[129],"after":[130],"24":[131],"h.":[132],"passive":[134],"cutaneous":[135],"anaphylaxis,":[136],"myocardial":[137],"infarction":[138],"bleomycin-induced":[140],"pulmonary":[141],"fibrosis":[142],"administered":[145],"inhibition":[149],"inflammatory":[151,176],"response,":[152,177],"angiotensin":[154,179],"II":[155,180],"formation,":[156],"fibrosis,":[158,192],"respectively.":[159],"These":[160],"data":[161,186],"suggest":[162],"that":[163],"has":[165],"vital":[167],"role":[168],"through":[172],"promotion":[173],"fibrosis.":[183],"Our":[184],"recent":[185],"participation":[189],"bladder":[191],"like":[193],"interstitial":[194],"cystitis.":[195],"Therefore,":[196],"active":[199],"may":[203],"protective":[205],"effects":[206],"on":[207],"several":[211],"diseases.":[212]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}